Please Wait.....
Report
Global Ophthalmic Drugs Market Forecast 2023-2032
Market Report I 2023-11-17 I 298 Pages I Inkwood Research
KEY FINDINGS
The global ophthalmic drugs market is predicted to project a CAGR of 6.09% during the forecast period, 2023-2032. The market growth is accredited to the vulnerability of the aging population to eye conditions associated with age, progress in drug delivery technologies, increasing incidence of eye diseases and disorders, and positive reimbursement policies implemented by healthcare systems.
MARKET INSIGHTS
Ophthalmic drugs play a crucial role in addressing a spectrum of eye-related conditions, including but not limited to glaucoma, age-related macular degeneration (AMD), dry eye syndrome, and diabetic retinopathy. Ophthalmic drugs encompass a diverse range of drug classes, including anti-inflammatory drugs, anti-infective drugs, anti-glaucoma drugs, and others. These drugs are tailored to address specific disease indications such as inflammation, infections, elevated intraocular pressure, and retinal disorders.
The global increase in the prevalence of eye diseases and disorders can be attributed to a combination of demographic, lifestyle, and environmental factors. One contributing factor is the widespread usage of digital devices, such as smartphones, computers, and tablets, leading to heightened exposure to the blue light emitted by these screens. Prolonged exposure to this blue light can result in digital eye strain, manifesting as symptoms like dry eyes, eye fatigue, and discomfort. Although not a disease on its own, digital eye strain has the potential to worsen existing eye conditions and adversely affect visual comfort.
However, patent expirations and the entry of generic drugs pose challenges to market growth. Untapped potential in emerging economies offers a growth avenue for market players.
REGIONAL INSIGHTS
The global ophthalmic drugs market growth evaluation includes the geographical analysis of North America, Europe, Asia-Pacific, and Rest of World. Asia-Pacific is the fastest-growing region in the global market, driven by various factors such as the increasing prevalence of eye disorders, rising aging population, and advancements in pharmaceutical research and development.
COMPETITIVE INSIGHTS
The market for ophthalmic drugs on a global scale is characterized by intense competition, as various pharmaceutical companies vie for a share of the market. Major players dedicate substantial resources to research and development endeavors aimed at introducing novel drugs and therapies, fostering a continuous cycle of innovation. Some of the leading companies in the market include AbbVie Inc, Genentech Inc, Bausch Health Companies Inc, etc.
Our report offerings include:
- Explore key findings of the overall market
- Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
- Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
- Market Segmentation caters to a thorough assessment of key segments with their market estimations
- Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
- Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
- The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
- Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.4.1. IMPACT OF COVID-19 ON OPHTHALMIC DRUGS MARKET
2.5. MAJOR MARKET FINDINGS
2.5.1. EMERGING THERAPIES FOR DRY EYE SYNDROME
2.5.2. GROWING DEMAND FOR COMBINATION THERAPIES
2.5.3. INCREASING INVESTMENT IN RESEARCH & DEVELOPMENT
2.5.4. SHIFT TOWARD OVER-THE-COUNTER (OTC) PRODUCTS
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. AGING POPULATION'S SUSCEPTIBILITY TO AGE-RELATED EYE CONDITIONS
3.1.2. ADVANCEMENTS IN DRUG DELIVERY TECHNOLOGIES
3.1.3. RISING PREVALENCE OF EYE DISEASES AND DISORDERS
3.1.4. FAVORABLE REIMBURSEMENT POLICIES BY HEALTHCARE SYSTEMS
3.2. KEY RESTRAINTS
3.2.1. DELAY IN DRUG APPROVALS
3.2.2. SIDE EFFECTS RELATED TO OPHTHALMIC DRUGS
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.2. TECHNOLOGY SNAPSHOT
4.2.1. BIOLOGICS
4.2.2. CELL THERAPY
4.2.3. GENE THERAPY
4.2.4. DRUG DELIVERY
4.2.5. SMALL MOLECULE
4.2.6. OTHER TECHNOLOGIES
4.3. PORTER'S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.4.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
4.4.2. GROWTH PROSPECT MAPPING FOR ITALY
4.4.3. GROWTH PROSPECT MAPPING FOR INDIA
4.4.4. GROWTH PROSPECT MAPPING FOR THE MIDDLE EAST & AFRICA
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. KEY BUYING CRITERIA
4.8. REGULATORY FRAMEWORK
5. MARKET BY INDICATION
5.1. DRY EYE
5.2. GLAUCOMA
5.3. INFECTION/INFLAMMATION/ALLERGIES
5.4. RETINAL DISORDER
5.4.1. WET AGE-RELATED MACULAR DEGENERATION
5.4.2. DRY AGE-RELATED MACULAR DEGENERATION
5.4.3. DIABETIC RETINOPATHY
5.4.4. OTHER RETINAL DISORDERS
5.5. OTHER INDICATIONS
6. MARKET BY TYPE
6.1. PRESCRIPTION DRUGS
6.2. OVER-THE-COUNTER DRUGS
7. MARKET BY DOSAGE FORM
7.1. GELS
7.2. EYE SOLUTIONS & SUSPENSIONS
7.3. CAPSULES & TABLETS
7.4. EYE DROPS
7.5. OINTMENTS
8. MARKET BY THERAPEUTIC CLASS
8.1. ANTI-GLAUCOMA
8.2. ANTI-INFECTION
8.3. ANTI-INFLAMMATORY
8.4. ANTI-ALLERGY
8.5. OTHER THERAPEUTIC CLASSES
9. MARKET BY DISTRIBUTION CHANNEL
9.1. HOSPITAL PHARMACIES
9.2. DRUG STORES
9.3. ONLINE PHARMACIES
9.4. OTHER DISTRIBUTION CHANNELS
10. GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1. MARKET SIZE & ESTIMATES
10.1.2. NORTH AMERICA OPHTHALMIC DRUGS MARKET DRIVERS
10.1.3. NORTH AMERICA OPHTHALMIC DRUGS MARKET CHALLENGES
10.1.4. KEY PLAYERS IN NORTH AMERICA OPHTHALMIC DRUGS MARKET
10.1.5. COUNTRY ANALYSIS
10.1.5.1. UNITED STATES
10.1.5.1.1. UNITED STATES OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.1.5.2. CANADA
10.1.5.2.1. CANADA OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.2. EUROPE
10.2.1. MARKET SIZE & ESTIMATES
10.2.2. EUROPE OPHTHALMIC DRUGS MARKET DRIVERS
10.2.3. EUROPE OPHTHALMIC DRUGS MARKET CHALLENGES
10.2.4. KEY PLAYERS IN EUROPE OPHTHALMIC DRUGS MARKET
10.2.5. COUNTRY ANALYSIS
10.2.5.1. UNITED KINGDOM
10.2.5.1.1. UNITED KINGDOM OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.2.5.2. GERMANY
10.2.5.2.1. GERMANY OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.2.5.3. FRANCE
10.2.5.3.1. FRANCE OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.2.5.4. ITALY
10.2.5.4.1. ITALY OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.2.5.5. SPAIN
10.2.5.5.1. SPAIN OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.2.5.6. BELGIUM
10.2.5.6.1. BELGIUM OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.2.5.7. POLAND
10.2.5.7.1. POLAND OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.2.5.8. REST OF EUROPE
10.2.5.8.1. REST OF EUROPE OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.3. ASIA-PACIFIC
10.3.1. MARKET SIZE & ESTIMATES
10.3.2. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET DRIVERS
10.3.3. ASIA-PACIFIC OPHTHALMIC DRUGS MARKET CHALLENGES
10.3.4. KEY PLAYERS IN ASIA-PACIFIC OPHTHALMIC DRUGS MARKET
10.3.5. COUNTRY ANALYSIS
10.3.5.1. CHINA
10.3.5.1.1. CHINA OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.3.5.2. JAPAN
10.3.5.2.1. JAPAN OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.3.5.3. INDIA
10.3.5.3.1. INDIA OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.3.5.4. SOUTH KOREA
10.3.5.4.1. SOUTH KOREA OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.3.5.5. INDONESIA
10.3.5.5.1. INDONESIA OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.3.5.6. THAILAND
10.3.5.6.1. THAILAND OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.3.5.7. VIETNAM
10.3.5.7.1. VIETNAM OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.3.5.8. AUSTRALIA & NEW ZEALAND
10.3.5.8.1. AUSTRALIA & NEW ZEALAND OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.3.5.9. REST OF ASIA-PACIFIC
10.3.5.9.1. REST OF ASIA-PACIFIC OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.4. REST OF WORLD
10.4.1. MARKET SIZE & ESTIMATES
10.4.2. REST OF WORLD OPHTHALMIC DRUGS MARKET DRIVERS
10.4.3. REST OF WORLD OPHTHALMIC DRUGS MARKET CHALLENGES
10.4.4. KEY PLAYERS IN REST OF WORLD OPHTHALMIC DRUGS MARKET
10.4.5. REGIONAL ANALYSIS
10.4.5.1. LATIN AMERICA
10.4.5.1.1. LATIN AMERICA OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
10.4.5.2. MIDDLE EAST & AFRICA
10.4.5.2.1. MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET SIZE & OPPORTUNITIES
11. COMPETITIVE LANDSCAPE
11.1. KEY STRATEGIC DEVELOPMENTS
11.1.1. MERGERS & ACQUISITIONS
11.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
11.1.3. PARTNERSHIPS & AGREEMENTS
11.2. COMPANY PROFILES
11.2.1. ABBVIE INC
11.2.1.1. COMPANY OVERVIEW
11.2.1.2. PRODUCTS & SERVICES
11.2.1.3. STRENGTHS & CHALLENGES
11.2.2. ACCUTOME INC
11.2.2.1. COMPANY OVERVIEW
11.2.2.2. PRODUCTS & SERVICES
11.2.2.3. STRENGTHS & CHALLENGES
11.2.3. BAUSCH HEALTH COMPANIES INC
11.2.3.1. COMPANY OVERVIEW
11.2.3.2. PRODUCTS & SERVICES
11.2.3.3. STRENGTHS & CHALLENGES
11.2.4. GENENTECH INC
11.2.4.1. COMPANY OVERVIEW
11.2.4.2. PRODUCTS & SERVICES
11.2.4.3. STRENGTHS & CHALLENGES
11.2.5. JOHNSON & JOHNSON
11.2.5.1. COMPANY OVERVIEW
11.2.5.2. PRODUCTS & SERVICES
11.2.5.3. STRENGTHS & CHALLENGES
11.2.6. THEA PHARMA INC
11.2.6.1. COMPANY OVERVIEW
11.2.6.2. PRODUCTS & SERVICES
11.2.6.3. STRENGTHS & CHALLENGES
11.2.7. NOVARTIS AG
11.2.7.1. COMPANY OVERVIEW
11.2.7.2. PRODUCTS & SERVICES
11.2.7.3. STRENGTHS & CHALLENGES
11.2.8. PFIZER INC
11.2.8.1. COMPANY OVERVIEW
11.2.8.2. PRODUCTS & SERVICES
11.2.8.3. STRENGTHS & CHALLENGES
11.2.9. REGENERON PHARMACEUTICALS INC
11.2.9.1. COMPANY OVERVIEW
11.2.9.2. PRODUCTS & SERVICES
11.2.9.3. STRENGTHS & CHALLENGES
11.2.10. SANTEN PHARMACEUTICAL CO LTD
11.2.10.1. COMPANY OVERVIEW
11.2.10.2. PRODUCTS & SERVICES
11.2.10.3. STRENGTHS & CHALLENGES
11.2.11. SUN PHARMACEUTICAL INDUSTRIES LTD
11.2.11.1. COMPANY OVERVIEW
11.2.11.2. PRODUCTS & SERVICES
11.2.11.3. STRENGTHS & CHALLENGES
11.2.12. TEVA PHARMACEUTICALS INDUSTRIES LTD
11.2.12.1. COMPANY OVERVIEW
11.2.12.2. PRODUCTS & SERVICES
11.2.12.3. STRENGTHS & CHALLENGES
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - OPHTHALMIC DRUGS
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: GLOBAL OPHTHALMIC DRUGS MARKET, BY INDICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 4: GLOBAL OPHTHALMIC DRUGS MARKET, BY INDICATION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 5: GLOBAL DRY EYE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 6: GLOBAL DRY EYE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 7: GLOBAL GLAUCOMA MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 8: GLOBAL GLAUCOMA MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 9: GLOBAL INFECTION/INFLAMMATION/ALLERGIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 10: GLOBAL INFECTION/INFLAMMATION/ALLERGIES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 11: GLOBAL RETINAL DISORDER MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 12: GLOBAL RETINAL DISORDER MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 13: GLOBAL OPHTHALMIC DRUGS MARKET, BY RETINAL DISORDER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 14: GLOBAL OPHTHALMIC DRUGS MARKET, BY RETINAL DISORDER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 15: GLOBAL WET AGE-RELATED MACULAR DEGENERATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 16: GLOBAL WET AGE-RELATED MACULAR DEGENERATION MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 17: GLOBAL DRY AGE-RELATED MACULAR DEGENERATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 18: GLOBAL DRY AGE-RELATED MACULAR DEGENERATION MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 19: GLOBAL DIABETIC RETINOPATHY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 20: GLOBAL DIABETIC RETINOPATHY MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 21: GLOBAL OTHER RETINAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 22: GLOBAL OTHER RETINAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 23: GLOBAL OTHER INDICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 24: GLOBAL OTHER INDICATIONS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 25: GLOBAL OPHTHALMIC DRUGS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 26: GLOBAL OPHTHALMIC DRUGS MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 27: GLOBAL PRESCRIPTION DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 28: GLOBAL PRESCRIPTION DRUGS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 29: GLOBAL OVER-THE-COUNTER DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 30: GLOBAL OVER-THE-COUNTER DRUGS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 31: GLOBAL OPHTHALMIC DRUGS MARKET, BY DOSAGE FORM, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 32: GLOBAL OPHTHALMIC DRUGS MARKET, BY DOSAGE FORM, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 33: GLOBAL GELS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 34: GLOBAL GELS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 35: GLOBAL EYE SOLUTIONS & SUSPENSIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 36: GLOBAL EYE SOLUTIONS & SUSPENSIONS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 37: GLOBAL CAPSULES & TABLETS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 38: GLOBAL CAPSULES & TABLETS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 39: GLOBAL EYE DROPS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 40: GLOBAL EYE DROPS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 41: GLOBAL OINTMENTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 42: GLOBAL OINTMENTS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 43: GLOBAL OPHTHALMIC DRUGS MARKET, BY THERAPEUTIC CLASS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 44: GLOBAL OPHTHALMIC DRUGS MARKET, BY THERAPEUTIC CLASS, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 45: GLOBAL ANTI-GLAUCOMA MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 46: GLOBAL ANTI-GLAUCOMA MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 47: GLOBAL ANTI-INFECTION MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 48: GLOBAL ANTI-INFECTION MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 49: GLOBAL ANTI-INFLAMMATORY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 50: GLOBAL ANTI-INFLAMMATORY MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 51: GLOBAL ANTI-ALLERGY MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 52: GLOBAL ANTI-ALLERGY MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 53: GLOBAL OTHER THERAPEUTIC CLASSES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 54: GLOBAL OTHER THERAPEUTIC CLASSES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 55: GLOBAL OPHTHALMIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 56: GLOBAL OPHTHALMIC DRUGS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 57: GLOBAL HOSPITAL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 58: GLOBAL HOSPITAL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 59: GLOBAL DRUG STORES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 60: GLOBAL DRUG STORES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 61: GLOBAL ONLINE PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 62: GLOBAL ONLINE PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 63: GLOBAL OTHER DISTRIBUTION CHANNELS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 64: GLOBAL OTHER DISTRIBUTION CHANNELS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 65: GLOBAL OPHTHALMIC DRUGS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 66: GLOBAL OPHTHALMIC DRUGS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 67: NORTH AMERICA OPHTHALMIC DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 68: NORTH AMERICA OPHTHALMIC DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 69: KEY PLAYERS OPERATING IN NORTH AMERICA OPHTHALMIC DRUGS MARKET
TABLE 70: EUROPE OPHTHALMIC DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 71: EUROPE OPHTHALMIC DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 72: KEY PLAYERS OPERATING IN EUROPE OPHTHALMIC DRUGS MARKET
TABLE 73: ASIA-PACIFIC OPHTHALMIC DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 74: ASIA-PACIFIC OPHTHALMIC DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 75: KEY PLAYERS OPERATING IN ASIA-PACIFIC OPHTHALMIC DRUGS MARKET
TABLE 76: REST OF WORLD OPHTHALMIC DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 77: REST OF WORLD OPHTHALMIC DRUGS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 78: KEY PLAYERS OPERATING IN REST OF WORLD OPHTHALMIC DRUGS MARKET
TABLE 79: LIST OF MERGERS & ACQUISITIONS
TABLE 80: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 81: LIST OF PARTNERSHIPS & AGREEMENTS
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES
FIGURE 4: GROWTH PROSPECT MAPPING FOR ITALY
FIGURE 5: GROWTH PROSPECT MAPPING FOR INDIA
FIGURE 6: GROWTH PROSPECT MAPPING FOR THE MIDDLE EAST & AFRICA
FIGURE 7: MARKET MATURITY ANALYSIS
FIGURE 8: MARKET CONCENTRATION ANALYSIS
FIGURE 9: GLOBAL OPHTHALMIC DRUGS MARKET, GROWTH POTENTIAL, BY INDICATION, IN 2022
FIGURE 10: GLOBAL OPHTHALMIC DRUGS MARKET, BY DRY EYE, 2023-2032 (IN $ MILLION)
FIGURE 11: GLOBAL OPHTHALMIC DRUGS MARKET, BY GLAUCOMA, 2023-2032 (IN $ MILLION)
FIGURE 12: GLOBAL OPHTHALMIC DRUGS MARKET, BY INFECTION/INFLAMMATION/ALLERGIES, 2023-2032 (IN $ MILLION)
FIGURE 13: GLOBAL OPHTHALMIC DRUGS MARKET, BY RETINAL DISORDER, 2023-2032 (IN $ MILLION)
FIGURE 14: GLOBAL OPHTHALMIC DRUGS MARKET, GROWTH POTENTIAL, BY RETINAL DISORDER, IN 2022
FIGURE 15: GLOBAL OPHTHALMIC DRUGS MARKET, BY WET AGE-RELATED MACULAR DEGENERATION, 2023-2032 (IN $ MILLION)
FIGURE 16: GLOBAL OPHTHALMIC DRUGS MARKET, BY DRY AGE-RELATED MACULAR DEGENERATION, 2023-2032 (IN $ MILLION)
FIGURE 17: GLOBAL OPHTHALMIC DRUGS MARKET, BY DIABETIC RETINOPATHY, 2023-2032 (IN $ MILLION)
FIGURE 18: GLOBAL OPHTHALMIC DRUGS MARKET, BY OTHER RETINAL DISORDERS, 2023-2032 (IN $ MILLION)
FIGURE 19: GLOBAL OPHTHALMIC DRUGS MARKET, BY OTHER INDICATIONS, 2023-2032 (IN $ MILLION)
FIGURE 20: GLOBAL OPHTHALMIC DRUGS MARKET, GROWTH POTENTIAL, BY TYPE, IN 2022
FIGURE 21: GLOBAL OPHTHALMIC DRUGS MARKET, BY PRESCRIPTION DRUGS, 2023-2032 (IN $ MILLION)
FIGURE 22: GLOBAL OPHTHALMIC DRUGS MARKET, BY OVER-THE-COUNTER DRUGS, 2023-2032 (IN $ MILLION)
FIGURE 23: GLOBAL OPHTHALMIC DRUGS MARKET, GROWTH POTENTIAL, BY DOSAGE FORM, IN 2022
FIGURE 24: GLOBAL OPHTHALMIC DRUGS MARKET, BY GELS, 2023-2032 (IN $ MILLION)
FIGURE 25: GLOBAL OPHTHALMIC DRUGS MARKET, BY EYE SOLUTIONS & SUSPENSIONS, 2023-2032 (IN $ MILLION)
FIGURE 26: GLOBAL OPHTHALMIC DRUGS MARKET, BY CAPSULES & TABLETS, 2023-2032 (IN $ MILLION)
FIGURE 27: GLOBAL OPHTHALMIC DRUGS MARKET, BY EYE DROPS, 2023-2032 (IN $ MILLION)
FIGURE 28: GLOBAL OPHTHALMIC DRUGS MARKET, BY OINTMENTS, 2023-2032 (IN $ MILLION)
FIGURE 29: GLOBAL OPHTHALMIC DRUGS MARKET, GROWTH POTENTIAL, BY THERAPEUTIC CLASS, IN 2022
FIGURE 30: GLOBAL OPHTHALMIC DRUGS MARKET, BY ANTI-GLAUCOMA, 2023-2032 (IN $ MILLION)
FIGURE 31: GLOBAL OPHTHALMIC DRUGS MARKET, BY ANTI-INFECTION, 2023-2032 (IN $ MILLION)
FIGURE 32: GLOBAL OPHTHALMIC DRUGS MARKET, BY ANTI-INFLAMMATORY, 2023-2032 (IN $ MILLION)
FIGURE 33: GLOBAL OPHTHALMIC DRUGS MARKET, BY ANTI-ALLERGY, 2023-2032 (IN $ MILLION)
FIGURE 34: GLOBAL OPHTHALMIC DRUGS MARKET, BY OTHER THERAPEUTIC CLASSES, 2023-2032 (IN $ MILLION)
FIGURE 35: GLOBAL OPHTHALMIC DRUGS MARKET, GROWTH POTENTIAL, BY DISTRIBUTION CHANNEL, IN 2022
FIGURE 36: GLOBAL OPHTHALMIC DRUGS MARKET, BY HOSPITAL PHARMACIES, 2023-2032 (IN $ MILLION)
FIGURE 37: GLOBAL OPHTHALMIC DRUGS MARKET, BY DRUG STORES, 2023-2032 (IN $ MILLION)
FIGURE 38: GLOBAL OPHTHALMIC DRUGS MARKET, BY ONLINE PHARMACIES, 2023-2032 (IN $ MILLION)
FIGURE 39: GLOBAL OPHTHALMIC DRUGS MARKET, BY OTHER DISTRIBUTION CHANNELS, 2023-2032 (IN $ MILLION)
FIGURE 40: NORTH AMERICA OPHTHALMIC DRUGS MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 41: UNITED STATES OPHTHALMIC DRUGS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 42: CANADA OPHTHALMIC DRUGS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 43: EUROPE OPHTHALMIC DRUGS MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 44: UNITED KINGDOM OPHTHALMIC DRUGS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 45: GERMANY OPHTHALMIC DRUGS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 46: FRANCE OPHTHALMIC DRUGS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 47: ITALY OPHTHALMIC DRUGS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 48: SPAIN OPHTHALMIC DRUGS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 49: BELGIUM OPHTHALMIC DRUGS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 50: POLAND OPHTHALMIC DRUGS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 51: REST OF EUROPE OPHTHALMIC DRUGS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 52: ASIA-PACIFIC OPHTHALMIC DRUGS MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 53: CHINA OPHTHALMIC DRUGS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 54: JAPAN OPHTHALMIC DRUGS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 55: INDIA OPHTHALMIC DRUGS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 56: SOUTH KOREA OPHTHALMIC DRUGS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 57: INDONESIA OPHTHALMIC DRUGS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 58: THAILAND OPHTHALMIC DRUGS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 59: VIETNAM OPHTHALMIC DRUGS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 60: AUSTRALIA & NEW ZEALAND OPHTHALMIC DRUGS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 61: REST OF ASIA-PACIFIC OPHTHALMIC DRUGS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 62: REST OF WORLD OPHTHALMIC DRUGS MARKET, REGIONAL OUTLOOK, 2022 & 2032 (IN %)
FIGURE 63: LATIN AMERICA OPHTHALMIC DRUGS MARKET, 2023-2032 (IN $ MILLION)
FIGURE 64: MIDDLE EAST & AFRICA OPHTHALMIC DRUGS MARKET, 2023-2032 (IN $ MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security